| Literature DB >> 29061505 |
Kazuhiro Koikawa1, Kenoki Ohuchida2, Shin Takesue1, Yohei Ando1, Shin Kibe1, Hiromichi Nakayama1, Sho Endo1, Toshiya Abe1, Takashi Okumura1, Kohei Horioka1, Masafumi Sada1, Chika Iwamoto3, Taiki Moriyama1, Kohei Nakata1, Yoshihiro Miyasaka1, Riichi Ohuchida4, Tatsuya Manabe1, Takao Ohtsuka1, Eishi Nagai1, Kazuhiro Mizumoto1, Makoto Hashizume3, Masafumi Nakamura2.
Abstract
Specific cell populations leading the local invasion of cancer are called "leading cells". However, the underlying mechanisms are unclear. Here, we identified leading cells in pancreatic cancer and determined how these cells lead and promote cancer cell invasion in the extracellular matrix (ECM). Using three-dimensional matrix remodeling assay, we found that pancreatic stellate cells (PSCs) frequently invaded the collagen matrix with pancreatic cancer cells (PCCs), which invaded behind the invading PSCs. In addition, invading PSCs changed the alignment of collagen fibers, resulting in ECM remodeling and an increase in the parallel fibers along the direction of invading PSCs. Endo180 expression was higher in PSCs than in PCCs, Endo180 knockdown in PSCs attenuated the invasive abilities of PSCs and co-cultured PCCs, and decreased the expression level of phosphorylated myosin light chain 2 (MLC2). In mouse models, Endo180-knockdown PSCs suppressed tumor growth and changes in collagen fiber orientation in co-transplantation with PCCs. Our findings suggest that PSCs lead the local invasion of PCCs by physically remodeling the ECM, possibly via the function of Endo180, which reconstructs the actin cell skeleton by phosphorylation of MLC2.Entities:
Keywords: Endo180; Extracellular matrix remodeling; Leading cells; Pancreatic cancer; Pancreatic stellate cells
Mesh:
Substances:
Year: 2017 PMID: 29061505 DOI: 10.1016/j.canlet.2017.10.010
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679